Ana León Rodríguez is addressing the issue of microglial priming in the brain, caused by events like traumatic brain injuries, leading to increased neurotoxicity and the risk of neurological diseases. Her solution involves developing a vaccine using the immunomodulatory properties of Mycobacterium vaccae, a soil-derived bacteria, to attenuate microglial priming and prevent the consequences for millions of people worldwide, offering a potential breakthrough in the prevention of diseases such as Alzheimer’s and Schizophrenia.

Further Activities to have a look at